Can Geriatric Assessment Measures Be Used to Determine Cancer Treatment Vulnerability in Nongeriatric Patients?
作者信息
Dharmarajan Kavita V, Mohile Supriya G
机构信息
Department of Radiation Oncology, Brookdale Department of Geriatrics and Palliative Medicine, the Icahn School of Medicine at Mount Sinai, New York, New York.
Division of Hematology/Oncology, Departments of Medicine and Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
出版信息
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):612-614. doi: 10.1016/j.ijrobp.2020.05.030.
Abstract
摘要
相似文献
1
Can Geriatric Assessment Measures Be Used to Determine Cancer Treatment Vulnerability in Nongeriatric Patients?
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):612-614. doi: 10.1016/j.ijrobp.2020.05.030.
2
Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):602-611. doi: 10.1016/j.ijrobp.2020.01.004. Epub 2020 Jan 25.
3
Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Cancer Control. 2022 Jan-Dec;29:10732748211045276. doi: 10.1177/10732748211045276.
4
Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
Auris Nasus Larynx. 2022 Apr;49(2):279-285. doi: 10.1016/j.anl.2021.08.009. Epub 2021 Sep 9.
5
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.
BMC Cancer. 2015 Nov 9;15:875. doi: 10.1186/s12885-015-1800-1.
6
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.
Eur J Cancer Care (Engl). 2014 May;23(3):401-12. doi: 10.1111/ecc.12179. Epub 2014 Jan 28.
7
Frailty in geriatric head and neck cancer: A contemporary review.
Laryngoscope. 2018 Dec;128(12):E416-E424. doi: 10.1002/lary.27339. Epub 2018 Oct 17.
8
Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):850-857. doi: 10.1016/j.ijrobp.2016.11.048. Epub 2016 Dec 2.
9
Concurrent chemoradiotherapy in older adults with squamous cell head & neck cancer: Evidence and management.
J Geriatr Oncol. 2016 May;7(3):145-53. doi: 10.1016/j.jgo.2016.01.010. Epub 2016 Feb 28.
10
Appropriately screened geriatric chest pain patients in an observation unit are not admitted at a higher rate than nongeriatric patients.
Crit Pathw Cardiol. 2008 Dec;7(4):245-7. doi: 10.1097/HPC.0b013e31818efb86.
引用本文的文献
1
Frailty is associated with poor outcomes in midlife trauma patients.
Am J Surg. 2025 Mar;241:116157. doi: 10.1016/j.amjsurg.2024.116157. Epub 2024 Dec 20.
2
Performance of two frailty screening tools among patients with cancer in Taiwan.
Biomed J. 2022 Apr;45(2):361-369. doi: 10.1016/j.bj.2021.03.002. Epub 2021 Mar 10.
3
Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Cancer Control. 2022 Jan-Dec;29:10732748211045276. doi: 10.1177/10732748211045276.
本文引用的文献
1
Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):602-611. doi: 10.1016/j.ijrobp.2020.01.004. Epub 2020 Jan 25.
2
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary.
J Oncol Pract. 2018 Jul;14(7):442-446. doi: 10.1200/JOP.18.00180. Epub 2018 Jun 22.
3
Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation.
Adv Radiat Oncol. 2017 Oct 23;3(1):62-69. doi: 10.1016/j.adro.2017.10.006. eCollection 2018 Jan-Mar.
4
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.
BMC Cancer. 2015 Nov 9;15:875. doi: 10.1186/s12885-015-1800-1.
5
Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.
Hepatology. 2016 Feb;63(2):574-80. doi: 10.1002/hep.28316. Epub 2015 Dec 16.
6
Compliance to therapy-elderly head and neck carcinoma patients.
Can Geriatr J. 2014 Sep 5;17(3):83-7. doi: 10.5770/cgj.17.101. eCollection 2014 Sep.
7
Development of a frailty framework among vulnerable populations.
ANS Adv Nurs Sci. 2014 Jan-Mar;37(1):70-81. doi: 10.1097/ANS.0000000000000013.
8
Performance of two geriatric screening tools in older patients with cancer.
J Clin Oncol. 2014 Jan 1;32(1):19-26. doi: 10.1200/JCO.2013.51.1345. Epub 2013 Nov 25.
9
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
Ann Oncol. 2014 Jan;25(1):216-25. doi: 10.1093/annonc/mdt461. Epub 2013 Nov 19.
10
Frailty as a predictor of morbidity and mortality in inpatient head and neck surgery.
JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):783-9. doi: 10.1001/jamaoto.2013.3969.
Zotero 插件